Q3 2024 · 13F-HR
Logos Global Management LPholdings as filed
Filed 2024-11-14 · accession 0001172661-24-005030
$926.8M
Reported value
55
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $66.5M | 7.18% | 2,100,000 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $54.9M | 5.92% | 1,250,000 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $54.4M | 5.87% | 1,200,000 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $45.9M | 4.96% | 935,000 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $45.4M | 4.90% | 1,000,000 | Common | SOLE |
| 68062P106 | OLMA | OLEMA PHARMACEUTICALS INC | $38.3M | 4.13% | 3,208,875 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $34.3M | 3.70% | 300,000 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $31.4M | 3.38% | 1,100,000 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $30.6M | 3.30% | 900,000 | Common | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $30.4M | 3.29% | 3,500,000 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $30.0M | 3.24% | 750,000 | Common | SOLE |
| 29479A108 | ERAS | ERASCA INC | $29.8M | 3.21% | 10,900,000 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $28.8M | 3.11% | 1,000,000 | CALL | SOLE |
| N5749R100 | 2GH | MERUS N V | $28.7M | 3.10% | 575,000 | Common | SOLE |
| 36315X101 | LKFT | GALAPAGOS NV | $23.0M | 2.48% | 800,000 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $23.0M | 2.48% | 800,000 | Common | SOLE |
| 25056L103 | DSGN | DESIGN THERAPEUTICS INC | $22.7M | 2.45% | 4,217,627 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $22.1M | 2.38% | 500,000 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $21.6M | 2.33% | 2,000,000 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $21.1M | 2.28% | 400,000 | Common | SOLE |
| 055477103 | BCAX | BICARA THERAPEUTICS INC | $20.4M | 2.20% | 800,000 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $18.7M | 2.02% | 150,000 | Common | SOLE |
| 03589W102 | ANNX | ANNEXON INC | $15.4M | 1.66% | 2,600,000 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $15.4M | 1.66% | 1,100,000 | Common | SOLE |
| 29337E102 | ELVN | ENLIVEN THERAPEUTICS INC | $12.6M | 1.36% | 495,000 | Common | SOLE |
| 07373V105 | BEAM | BEAM THERAPEUTICS INC | $12.3M | 1.32% | 500,000 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $12.0M | 1.30% | 450,000 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $11.3M | 1.22% | 500,000 | Common | SOLE |
| 984241109 | YMABUSD | Y-MABS THERAPEUTICS INC | $10.5M | 1.14% | 800,000 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $9.9M | 1.06% | 400,000 | Common | SOLE |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $9.2M | 0.99% | 2,750,000 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $7.7M | 0.83% | 75,000 | Common | SOLE |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $7.3M | 0.79% | 1,159,030 | Common | SOLE |
| 687604108 | ORKA | ORUKA THERAPEUTICS INC | $6.3M | 0.68% | 257,330 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $6.0M | 0.65% | 325,000 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $5.9M | 0.63% | 200,000 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $5.7M | 0.62% | 160,000 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $5.5M | 0.59% | 500,000 | Common | SOLE |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $5.4M | 0.58% | 1,500,000 | CALL | SOLE |
| 23256X407 | HELP | CYBIN INC | $5.3M | 0.58% | 600,000 | Common | SOLE |
| 29286M105 | — | ENGENE HOLDINGS INC | $5.3M | 0.57% | 800,000 | Common | SOLE |
| 05338F306 | AVTX | AVALO THERAPEUTICS INC | $5.1M | 0.55% | 539,079 | Common | SOLE |
| 53566P109 | LCTX | LINEAGE CELL THERAPEUTICS IN | $4.5M | 0.49% | 5,000,000 | Common | SOLE |
| 75383L102 | RAPP | RAPPORT THERAPEUTICS INC | $4.1M | 0.44% | 208,910 | Common | SOLE |
| 82686Q101 | SLN | SILENCE THERAPEUTICS PLC | $3.6M | 0.39% | 200,000 | Common | SOLE |
| 002120202 | ATYR | ATYR PHARMA INC | $3.5M | 0.38% | 2,000,000 | Common | SOLE |
| 65343E108 | NXTCEUR | NEXTCURE INC | $3.4M | 0.37% | 2,500,000 | Common | SOLE |
| 00773U207 | AVU0 | ADVERUM BIOTECHNOLOGIES INC | $2.9M | 0.32% | 416,666 | Common | SOLE |
| 04317A107 | ARTV | ARTIVA BIOTHERAPEUTICS INC | $2.1M | 0.23% | 145,089 | Common | SOLE |
| 90466Y103 | — | UNICYCIVE THERAPEUTICS INC | $2.1M | 0.22% | 5,078,927 | Common | SOLE |
| 01671P100 | ALLKGUSD | ALLAKOS INC | $1.9M | 0.20% | 2,900,000 | Common | SOLE |
| 640979100 | NMRA | NEUMORA THERAPEUTICS INC. | $1.3M | 0.14% | 100,000 | Common | SOLE |
| 449778109 | IOBTQ | IO BIOTECH INC | $518,518 | 0.06% | 493,827 | Common | SOLE |
| 83086J200 | SKYE | SKYE BIOSCIENCE INC | $391,000 | 0.04% | 100,000 | Common | SOLE |
| 10170A100 | BOLD | BOUNDLESS BIO INC | $204,393 | 0.02% | 58,903 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.